Research Article| Volume 67, ISSUE 3, P285-294, June 2003

Download started.


Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer


      Background and purpose: To compare the rectal wall and bladder volume in the high dose region with or without the use of a balloon catheter with both three-dimensional (3D)-conformal and intensity modulated radiation therapy (CRT, IMRT) approaches in the treatment of prostate cancer.
      Material and methods: Five patients with a wide range of prostate volumes and treated with primary external beam radiation therapy for localized prostate cancer were selected for analysis. Pinnacle™ treatment plans were generated utilizing a 3D conformal six-field design and an IMRT seven coplanar-field plan with a novel, three-step optimization and with ultrasound localization. Separate plans were devised with a rectal balloon deflated or air inflated with and without inclusion of the seminal vesicles (SV) in the target volume. The prescription dose was 76 Gy in 38 fractions of 2 Gy each. Cumulative dose–volume histograms (DVHs) were analyzed for the planning target volume (PTV), rectal wall, and bladder with an inflated (60 cc air) or deflated balloon with and without SV included. The volumes of rectal wall and bladder above 60, 65, and 70 Gy with each treatment approach were evaluated.
      Results: Daily balloon placement was well-tolerated with good patient positional reproducibility. Inflation of the rectal balloon in all cases resulted in a significant decrease in the absolute volume of rectal wall receiving greater than 60, 65, or 70 Gy. The rectal sparing ratio (RSR), consisting of a structure's high dose volume with the catheter inflated, divided by the volume with the catheter deflated, was calculated for each patient with and without seminal vesicle inclusion for 3D-CRT and IMRT. For 3D-CRT, RSRs with SV included were 0.59, 0.59, and 0.56 and with SV excluded were 0.60, 0.58, and 0.54 at doses of greater than 60, 65, and 70 Gy, respectively. Similarly, for IMRT, the mean RSRs were 0.59, 0.59, and 0.63 including SV and 0.71, 0.66, and 0.67 excluding SV at these same dose levels, respectively. Averaged over all conditions, inflation of the rectal balloon resulted in a significant reduction in rectal volume receiving ≥65 Gy to a mean ratio of 0.61 (P=0.01) or, in other words, a mean fractional high dose rectal sparing of 39%. There was a slight overall increase to 1.13 in the relative volume of bladder receiving at least 65 Gy; however, this was not significant (P=0.6). Use of an endorectal balloon with a non-image-guided 3D-CRT plan produced about as much rectal dose sparing as a highly conformal, image-guided IMRT approach without a balloon. However, inclusion of a balloon with IMRT produced further rectal sparing still.
      Conclusion: These results indicate that use of a rectal balloon with a 3D-CRT plan incorporating typical treatment margins will produce significant high dose rectal sparing that is comparable to that achieved by a highly conformal IMRT with ultrasound localization. Further sparing is achieved with the inclusion of a balloon catheter in an IMRT plan. Thus, in addition to a previously reported advantage of prostate immobilization, the use of a rectal displacement balloon during daily treatment results in high dose rectal wall sparing during both modestly and highly conformal radiotherapy. Such sparing could assist in controlling and limiting rectal toxicity during increasingly aggressive dose escalation.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Radiotherapy and Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hanks G.E.
        • Hanlon A.L.
        • Schultheiss T.E.
        • et al.
        Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.
        Int J Radiat Oncol Biol Phys. 1998; 41: 501-510
        • Pollack A.
        • Zagars G.K.
        • Smith L.G.
        • et al.
        Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer.
        J Clin Oncol. 2000; 18: 3904-3911
        • Zelefsky M.J.
        • Leibel S.A.
        • Gaudin P.B.
        • et al.
        Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.
        Int J Radiat Oncol Biol Phys. 1998; 41: 491-500
        • Michalski J.M.
        • Purdy J.A.
        • Winter K.
        • et al.
        Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
        Int J Radiat Oncol Biol Phys. 2000; 46: 391-402
        • Schultheiss T.E.
        • Lee W.R.
        • Hunt M.A.
        • et al.
        Late GI and GU complications in the treatment of prostate cancer.
        Int J Radiat Oncol Biol Phys. 1997; 37: 3-11
        • Storey M.R.
        • Pollack A.
        • Zagars G.
        • et al.
        Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial.
        Int J Radiat Oncol Biol Phys. 2000; 48: 635-642
        • Teshima T.
        • Hanks G.E.
        • Hanlon A.L.
        • et al.
        Rectal bleeding after conformal 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity.
        Int J Radiat Oncol Biol Phys. 1997; 39: 77-83
        • Dearnaley D.P.
        • Khoo V.S.
        • Norman A.R.
        • et al.
        Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial.
        Lancet. 1999; 353: 267-272
        • Koper P.C.
        • Stroom J.C.
        • van Putten W.L.
        • et al.
        Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study.
        Int J Radiat Oncol Biol Phys. 1999; 43: 727-734
        • McGary J.
        • Teh B.
        • Grant W.
        Prostate immobilization with rectal catheter/balloon for IMRT: a prostate motion study.
        ASTRO. 2001; ([abstract])
        • Teh B.S.
        • Mai W.Y.
        • Uhl B.M.
        • et al.
        Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose–volume analysis.
        Int J Radiat Oncol Biol Phys. 2001; 49: 705-712
        • Lattanzi J.
        • McNeely S.
        • Hanlon A.
        • et al.
        Daily CT localization for correcting portal errors in the treatment of prostate cancer.
        Int J Radiat Oncol Biol Phys. 1998; 41: 1079-1086
        • Lattanzi J.
        • McNeeley S.
        • Pinover W.
        • et al.
        A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer.
        Int J Radiat Oncol Biol Phys. 1999; 43: 719-725
        • D'Amico A.V.
        • Manola J.
        • Loffredo M.
        • et al.
        A practical method to achieve prostate gland immobilization and target verification for daily treatment.
        Int J Radiat Oncol Biol Phys. 2001; 51: 1431-1436
        • Boersma L.J.
        • van den Brink M.
        • Bruce A.M.
        • et al.
        Estimation of the incidence of late bladder and rectum complications after high-dose (70–78 GY) conformal radiotherapy for prostate cancer, using dose–volume histograms.
        Int J Radiat Oncol Biol Phys. 1998; 41: 83-92
        • Marks L.B.
        • Carroll P.R.
        • Dugan T.C.
        • et al.
        The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy.
        Int J Radiat Oncol Biol Phys. 1995; 31: 1257-1280
        • Nguyen L.N.
        • Pollack A.
        • Zagars G.K.
        Late effects after radiotherapy for prostate cancer in a randomized dose–response study: results of a self-assessment questionnaire.
        Urology. 1998; 51: 991-997
        • Zelefsky M.
        • Fuks Z.
        • Happersett L.
        • et al.
        Improved conformality and reduced toxicity with high-dose intensity modulated radiation therapy (IMRT) for patients with prostate cancer.
        Int J Radiat Oncol Biol Phys. 1999; 45: 170
        • Lu Y.
        • Song P.Y.
        • Li S.D.
        • et al.
        A method of analyzing rectal surface area irradiated and rectal complications in prostate conformal radiotherapy.
        Int J Radiat Oncol Biol Phys. 1995; 33: 1121-1125
        • Wachter S.
        • Gerstner N.
        • Dorner D.
        • et al.
        The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose–volume histograms during treatment course of conformal radiotherapy for prostate cancer.
        Int J Radiat Oncol Biol Phys. 2002; 52: 91-100